"CF Sales Trajectory is Sufficiently Reflected in the Stock at Current Levels" - Needham & Company Maintains Vertex (VRTX) at Hold
Go back to "CF Sales Trajectory is Sufficiently Reflected in the Stock at Current Levels" - Needham & Company Maintains Vertex (VRTX) at Hold| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 529.65 +5.74 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $523.91 | 52 Week High | $134.71 | |||
| Open | $525.02 | 52 Week Low | $73.31 | |||
| Day High | $532.23 | P/E | N/A | |||
| Day Low | $522.01 | EPS | $-1.98 | |||
| Volume | 1,065,441 | |||||
